PubMed

Predictive factors of visual and anatomical outcome after intravitreal bevacizumab treatment of neovascular age-related macular degeneration: an optical coherence tomography study.

Singh RP, Fu EX, Smith SD, Williams DR, Kaiser PK.

Br J Ophthalmol. 2009 Oct;93(10):1353-8. Epub 2009 Jun 24.PMID: 19556212 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.PMID: 17420694 [PubMed - indexed for MEDLINE]Related articles

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94.PMID: 18827735 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study.

Weigert G, Michels S, Sacu S, Varga A, Prager F, Geitzenauer W, Schmidt-Erfurth U.

Br J Ophthalmol. 2008 Mar;92(3):356-60.PMID: 18303156 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) treatment of neovascular age-related macular degeneration.

Emerson MV, Lauer AK, Flaxel CJ, Wilson DJ, Francis PJ, Stout JT, Emerson GG, Schlesinger TK, Nolte SK, Klein ML.

Retina. 2007 Apr-May;27(4):439-44.PMID: 17420695 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.

Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.

Am J Ophthalmol. 2006 Jul;142(1):1-9.PMID: 16815245 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment-naïve subfoveal occult choroidal neovascularization in age-related macular degeneration.

Furino C, Boscia F, Recchimurzo N, Besozzi G, Cardascia N, Sborgia L, Niro A, Sborgia C.

Acta Ophthalmol. 2009 Jun;87(4):404-7. Epub 2008 Sep 8.PMID: 18782335 [PubMed - indexed for MEDLINE]Related articles

Quantitative comparison of optical coherence tomography after pegaptanib or bevacizumab in neovascular age-related macular degeneration.

Joeres S, Kaplowitz K, Brubaker JW, Updike PG, Collins AT, Walsh AC, Romano PW, Sadda SR.

Ophthalmology. 2008 Feb;115(2):347-354.e2. Epub 2007 Jul 12.PMID: 17628685 [PubMed - indexed for MEDLINE]Related articles

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration.

Ahmadieh H, Taei R, Soheilian M, Riazi-Esfahani M, Karkhaneh R, Lashay A, Azarmina M, Dehghan MH, Moradian S.

BMC Ophthalmol. 2007 Jun 7;7:10.PMID: 17555600 [PubMed - indexed for MEDLINE]Related articlesFree article

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

Retina. 2006 May-Jun;26(5):495-511.PMID: 16770255 [PubMed - indexed for MEDLINE]Related articles

Treatment of choroidal neovascularization using intravitreal bevacizumab.

Pedersen R, Soliman W, Lund-Andersen H, Larsen M.

Acta Ophthalmol Scand. 2007 Aug;85(5):526-33. Epub 2007 May 18.PMID: 17511757 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration using a variable frequency regimen in eyes with no previous treatment.

Fong KC, Kirkpatrick N, Mohamed Q, Johnston RL.

Clin Experiment Ophthalmol. 2008 Nov;36(8):748-55.PMID: 19128380 [PubMed - indexed for MEDLINE]Related articles

Visual improvement following intravitreal bevacizumab (Avastin) in exudative age-related macular degeneration.

Yoganathan P, Deramo VA, Lai JC, Tibrewala RK, Fastenberg DM.

Retina. 2006 Nov-Dec;26(9):994-8.PMID: 17151485 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.

Ophthalmology. 2006 Mar;113(3):363-372.e5. Epub 2006 Feb 3.PMID: 16458968 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: the second year of a prospective study.

Bashshur ZF, Haddad ZA, Schakal AR, Jaafar RF, Saad A, Noureddin BN.

Am J Ophthalmol. 2009 Jul;148(1):59-65.e1. Epub 2009 Apr 18.PMID: 19375689 [PubMed - indexed for MEDLINE]Related articles

Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: twenty-four-week results of an uncontrolled open-label clinical study.

Moshfeghi AA, Rosenfeld PJ, Puliafito CA, Michels S, Marcus EN, Lenchus JD, Venkatraman AS.

Ophthalmology. 2006 Nov;113(11):2002.e1-12. Epub 2006 Oct 5.PMID: 17027972 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study.

Bashshur ZF, Haddad ZA, Schakal A, Jaafar RF, Saab M, Noureddin BN.

Am J Ophthalmol. 2008 Feb;145(2):249-256. Epub 2007 Dec 11.PMID: 18067876 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.PMID: 17186262 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab for subfoveal choroidal neovascularization secondary to age-related macular degeneration in an Indian population.

Azad RV, Khan MA, Chanana B, Azad S.

Jpn J Ophthalmol. 2008 Jan-Feb;52(1):52-6. Epub 2008 Mar 28.PMID: 18369701 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage.

Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C, Schmidt-Erfurth U.

Am J Ophthalmol. 2007 Dec;144(6):886-892. Epub 2007 Oct 4.PMID: 17916314 [PubMed - indexed for MEDLINE]Related articles